Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and Nasopharyngeal Neoplasms

arsenic trioxide has been researched along with Nasopharyngeal Neoplasms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (69.23)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flemington, EK; Lasky, JA; Lin, Z; Luo, F; Sides, MD; Sosulski, ML1
Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H; Zhou, K1
Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H1
Ahn, KJ; Bae, IJ; Choi, IH; Choi, IW; Eun, CK; Jung, JJ; Kang, MS; Lee, SW; Lew, YS; Park, CW; Park, SG; Seo, SK; Won, HJ1
Ahn, R; Chen, H; O'Halloran, TV; Thompson, DH; Van den Bossche, J1
Hu, JL; Liang, HH; Qiu, ZD; Zhang, YF1
Chang, JW; Li, YY; Wang, CH; Wang, HM; Yeh, KY1
Du, CW; Li, DR; Lin, YC; Wu, MY1
Chen, JY; Chen, L; Du, CW; Li, DR; Lin, W; Lin, YC; Wen, BG; Wu, MY; Zheng, YW1
Chen, JY; Du, CW; Hong, CQ; Hong, X; Li, DR; Lin, YC; Lin, ZZ; Peng, X; Wen, BG; Wu, MY; Xie, LX; Zhang, H1
Au, WY; Chan, EY; Cheng, VC; Kumana, CR; Kwong, YL; Lam, CW; Liu, R; Shek, TW1
Chen, JY; Du, CW; Hong, CQ; Li, DR; Lin, XH; Xie, LX1
Li, DR; Lin, W; Lin, YC1

Trials

1 trial(s) available for arsenic trioxide and Nasopharyngeal Neoplasms

ArticleYear
[Relationship between radiotherapy enhancing effect of arsenic trioxide and the proliferation and apoptosis of related protein in nasopharyngeal carcinoma patients].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:8

    Topics: Adult; Aged; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Proliferation; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nasopharyngeal Neoplasms; Oxides; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Young Adult

2007

Other Studies

12 other study(ies) available for arsenic trioxide and Nasopharyngeal Neoplasms

ArticleYear
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
    Virology journal, 2013, May-16, Volume: 10

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Heterografts; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Treatment Outcome; Tumor Burden

2013
[Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2013, Volume: 27, Issue:9

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; Death-Associated Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Xenograft Model Antitumor Assays

2013
[Effects of arsenic trioxide combined with cisplatin on the growth of human nasopharyngeal carcinoma cells and reversion of RASSF1A hympermethylation].
    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2014, Volume: 28, Issue:14

    Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; DNA Methylation; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Oxides; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2014
Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effect.
    Cancer letters, 2009, May-18, Volume: 277, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Squamous Cell; Oxides; Radiation Tolerance; Transplantation, Heterologous

2009
Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:7

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Drug Carriers; Drug Delivery Systems; Female; Flow Cytometry; Folic Acid; Humans; Liposomes; Nanoparticles; Nasopharyngeal Neoplasms; Oxides; Tumor Cells, Cultured

2009
[Induced RAS association domain family gene 1A gene expression by arsenic trioxide in nasopharyngeal carcinoma cell].
    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2009, Volume: 44, Issue:10

    Topics: Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; DNA Methylation; Gene Expression; Humans; Nasopharyngeal Neoplasms; Oxides; RNA, Messenger; Tumor Suppressor Proteins

2009
Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
    Head & neck, 2011, Volume: 33, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Inbred BALB C; Nasopharyngeal Neoplasms; Oxides; Xenograft Model Antitumor Assays

2011
[Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model].
    Ai zheng = Aizheng = Chinese journal of cancer, 2003, Volume: 22, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Oxides; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003
Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
    Experimental oncology, 2005, Volume: 27, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Southern; Cell Line, Tumor; Cell Proliferation; Herpesvirus 4, Human; Humans; In Situ Nick-End Labeling; Nasopharyngeal Neoplasms; Oxides; Telomere; Viral Matrix Proteins

2005
Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2006, Volume: 39, Issue:5

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Microscopy, Confocal; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Viral Matrix Proteins

2006
Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
    Leukemia research, 2007, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Arsenic Trioxide; Arsenicals; Colonic Neoplasms; Female; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Male; Nasopharyngeal Neoplasms; Neoplasms; Oxides

2007
Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts.
    Experimental oncology, 2007, Volume: 29, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Combined Modality Therapy; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Nasopharyngeal Neoplasms; Oxides; Transplantation, Heterologous

2007